Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Afatinib

Skeletal muscule loss

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Nie X, et al. EP12.01-09 Predictive and Prognostic Value of Early Skeletal Muscle Loss during First-Line EGFR-TKIs for Advanced Lung Adenocarcinoma. Journal of Thoracic Oncology 18 (Suppl.): S643-S644 abstr. EP12.01-09, No. 11, Nov 2023. Available from: URL: https://dx.doi.org/10.1016/j.jtho.2023.09.1224 [abstract] Nie X, et al. EP12.01-09 Predictive and Prognostic Value of Early Skeletal Muscle Loss during First-Line EGFR-TKIs for Advanced Lung Adenocarcinoma. Journal of Thoracic Oncology 18 (Suppl.): S643-S644 abstr. EP12.01-09, No. 11, Nov 2023. Available from: URL: https://dx.doi.org/10.1016/j.jtho.2023.09.1224 [abstract]
Metadaten
Titel
Afatinib
Skeletal muscule loss
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55866-2

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Colchicine

Case report

Sulfadiazine

Case report

Multiple drugs

Case report

Labetalol

Case report

Iodine